[1]
Gutiérrez, J.M.; Calvete, J.J.; Habib, A.G.; Harrison, R.A.; Williams, D.J.; Warrell, D.A. Snakebite envenoming. Nat. Rev. Dis. Primers, 2017, 3, 17063.
[2]
Gutiérrez, J.M.; Fan, H.W.; Silvera, C.L.; Angulo, Y. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop. Toxicon, 2009, 53(6), 625-630.
[4]
Goyffon, M. Review article venoms, antivenoms and immunotherapy. Toxicon, 1998, 36(6), 823-846.
[5]
Carvalho, B.M.; Santos, J.D.; Xavier, B.M.; Almeida, J.R.; Resende, L.M.; Martins, W.; Marcussi, S.; Marangoni, S.; Stábeli, R.G.; Calderon, L.A.; Soares, A.M.; Da Silva, S.L.; Marchi-Salvador, D.P. Snake venom PLA2s inhibitors isolated from brazilian plants: Synthetic and natural molecules. BioMed Res. Int., 2013, 2013, 1-8.
[6]
Soares, A.M.; Ticli, F.K.; Marcussi, S.; Lourenço, M.V.; Januário, A.H.; Sampaio, S.V.; Giglio, J.R.; Lomonte, B.; Pereira, P.S. Medicinal plants with inhibitory properties against snake venoms. Curr. Med. Chem., 2005, 12(22), 2625-2641.
[7]
Guimaraes, C.L.; Moreira-Dill, L.S.; Fernandes, R.S.; Costa, T.R.; Hage-Melim, L.I.; Marcussi, S.; Carvalha, B.M.; Da Silva, S.L.; Zuliani, J.P.; Fernandes, C.F.; Calderson, L.A.; Soares, A.M.; Stabeli, R.G. Biodiversity as a source of bioactive compounds against snakebites. Curr. Med. Chem., 2014, 21(25), 2952-2979.
[8]
Soares, A.M.; Januário, A.H.; Lourenço, M.V.; Pereira, A.M.S.; Pereira, P.S. Neutralizing effects of Brazilian plants against snake venoms. Drugs Future, 2004, 29(11), 1105.
[9]
Félix-Silva, J.; Silva-Junior, A.A.; Zucolotto, S.M.; Fernandes-Pedrosa, M.F. Medicinal plants for the treatment of local tissue damage induced by snake venoms: an overview from traditional use to pharmacological evidence. Evid-based Compl. Alt., 2017, 2017, 1-52.
[10]
Campos, P.C.; Melo, L.A.; Dias, G.L.F.; Fortes-Dias, C.L. Endogenous phospholipase A2 inhibitors in snakes: a brief overview. J. Venom. Anim. Toxins Trop. Dis, 2016, 22(1), 37.
[11]
Dunn, R.D.; Broady, K.W. Snake inhibitors of phospholipase A2 enzymes. Biochim. Biophys. Acta, 2001, 1533(1), 29-37.
[12]
Stocker, K.; Barlow, G.H. The coagulant enzyme from Bothrops atrox venom (batroxobin). Methods Enzymol., 1976, 45, 214-223.
[13]
Cai, X.B.; Zhu, Z.S.; Zhang, M.Z.; Guo, J.; Wang, H.L. Effect of plasma fibrinogen level-based defibrase therapy in patients with acute cerebral infation. J. South. Med. Uni., 2009, 29(10), 2124-2127.
[14]
Dascombe, W.H.; Dumanian, G.; Hong, C.; Heil, B.V.; Labadie, K.; Hessel, B.; Blombäck, B.; Johnson, P.C. Application of thrombin based fibrin glue and non-thrombin based batroxobin glue on intact human blood vessels: evidence for transmural thrombin activity. Thromb. Haemost., 1997, 78(2), 947-951.
[15]
de Castro, I.; Burdmann, E.A.; Seguro, A.C.; Yu, L. Bothrops venom induces direct renal tubular injury: Role for lipid peroxidation and prevention by antivenom. Toxicon, 2004, 43(7), 833-839.
[16]
Soares, A.M. Use of snake venom for biomedical researches and drug development. J. Biochem. Biotech., 2012, 1, 1-3.
